BUY Kalyan Jewellers India Limited — Rajesh Palviya, Axis Securities
byRajesh Palviya, Axis SecuritiesHorizon: NA (inferred Swing (≤2wk))28 Aug 2026via Zee Business (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Raja Venkatraman Outlines Technical Outlook for Zydus, Kalyan, Uno Minda
NewsGoogle News·28 Aug · 4d ago
MarketSmith India Highlights Growth Drivers for Kalyan Jewellers and BHEL
NewsGoogle News·28 Aug · 4d ago
Kalyan Jewellers & BHEL: சந்தை சரிவிலும் கவனம் ஈர்க்கும் பங்குகள்! வளர்ச்சிக்கு என்ன காரணம்?
NewsGoogle News·28 Aug · 4d ago
Sunshine Pictures, Shankesh Jewellers Debut With 10% Gains
NewsGoogle News·25 Aug · 6d ago
Shankesh Jewellers shares list at 11% premium over IPO price on NSE
NewsGoogle News·25 Aug · 1w ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Kalyan Jewellers India
- SELL — Prakash Gaba23 Oct 2026 · ~2 weeks · target ₹510 · Target hit
- BUY — Arun Kumar Mantri21 Oct 2026 · ~2 weeks · target ₹597 · SL hit
- BUY — Deven Mehata, IDBI Capital Markets and Securities7 Oct 2026 · ~2 weeks · target ₹640 · Expired
- BUY — Dharmesh Kant, Cholamandalam Securities7 Oct 2026 · ~1 year · target ₹630 · Active
- BUY — Kunal Bothra5 Oct 2026 · ~3 months · target ₹640 · Active
More from Rajesh Palviya, Axis Securities
- BUY Sansera Engineering8 Oct 2026 · ~2 weeks · target ₹4,350 · SL hit
- BUY Trent8 Oct 2026 · ~2 weeks · target ₹3,050 · SL hit
- SELL Sun Pharmaceutical Industries5 Oct 2026 · ~3 months · target ₹1,720 · SL hit
- BUY Cipla29 Sept 2026 · ~2 weeks · target ₹1,480 · SL hit
- BUY Zydus Lifesciences29 Sept 2026 · ~2 weeks · target ₹1,280 · SL hit

